1
|
Zbucka-Kretowska M, Kuzmicki M, Telejko B, Goscik J, Ciborowski M, Lipinska D, Hryniewicka J, Citko A, Lawicki S, Wolczynski S. First-trimester irisin and fetuin-A concentration in predicting macrosomia. J Matern Fetal Neonatal Med 2018; 32:2868-2873. [PMID: 29562796 DOI: 10.1080/14767058.2018.1450859] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Objective: We investigated the diagnostic value of first-trimester adipokines and placental markers in predicting macrosomia. Methods: Out of 328 women recruited during the prenatal diagnosis between 11th and 13th week of pregnancy and subjected to follow up until delivery, we selected 26 women who gave birth to macrosomic babies and 34 women who gave birth to normal weight neonates for the evaluation of first trimester serum levels of pregnancy associated plasma protein-A, free β-human chorionic gonadotropin, placental growth factor (PIGF), and selected adipokines. Results: The mothers of macrosomic infants had higher PIGF (p = .049) and irisin concentrations (p = .00003), and lower fetuin-A levels (p = .0002) than had the mothers of normal weight babies. Newborn's weight correlated positively with maternal irisin (R = 0.454, p = .0003) and negatively with fetuin-A concentrations (R = -0.497, p = .00005). Multiple regression analysis showed that only serum irisin concentration was a significant predictor of birth weight (β = 0.329, p = .03), explaining 14% of its variability. The sensitivity and the specificity of irisin concentration in predicting macrosomia were 0.769 and 0.794, respectively (AUC = 0.818 [95%CI: 0.708-0.928], p = .00001) with a proposed cut-off value of 1725.4 ng/ml. Conclusions: Our results suggest that mother's irisin may be an early biomarker of macrosomia.
Collapse
Affiliation(s)
- Monika Zbucka-Kretowska
- a Department of Reproduction and Gynecological Endocrinology , Medical University of Bialystok , Bialystok , Poland
| | - Mariusz Kuzmicki
- b Department of Gynaecology and Gynecological Oncology , Medical University of Bialystok , Bialystok , Poland
| | - Beata Telejko
- c Department of Endocrinology, Diabetology and Internal Medicine , Medical University of Bialystok , Bialystok , Poland
| | - Joanna Goscik
- d Department of Software Engineering, Faculty of Computer Science , University of Technology Bialystok , Bialystok , Poland
| | - Michal Ciborowski
- e Clinical Research Centre , Medical University of Bialystok , Bialystok , Poland
| | - Danuta Lipinska
- c Department of Endocrinology, Diabetology and Internal Medicine , Medical University of Bialystok , Bialystok , Poland
| | - Justyna Hryniewicka
- c Department of Endocrinology, Diabetology and Internal Medicine , Medical University of Bialystok , Bialystok , Poland
| | - Anna Citko
- e Clinical Research Centre , Medical University of Bialystok , Bialystok , Poland
| | - Slawomir Lawicki
- f Department of Biochemical Diagnostics , Medical University of Bialystok , Bialystok , Poland
| | - Slawomir Wolczynski
- a Department of Reproduction and Gynecological Endocrinology , Medical University of Bialystok , Bialystok , Poland
| |
Collapse
|